These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 12657184)
1. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma. Rhines LD; Sampath P; DiMeco F; Lawson HC; Tyler BM; Hanes J; Olivi A; Brem H Neurosurgery; 2003 Apr; 52(4):872-9; discussion 879-80. PubMed ID: 12657184 [TBL] [Abstract][Full Text] [Related]
2. Local delivery of interleukin-2 and adriamycin is synergistic in the treatment of experimental malignant glioma. Hsu W; Lesniak MS; Tyler B; Brem H J Neurooncol; 2005 Sep; 74(2):135-40. PubMed ID: 16193383 [TBL] [Abstract][Full Text] [Related]
3. O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma. Rhines LD; Sampath P; Dolan ME; Tyler BM; Brem H; Weingart J Cancer Res; 2000 Nov; 60(22):6307-10. PubMed ID: 11103789 [TBL] [Abstract][Full Text] [Related]
4. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors. Sipos EP; Tyler B; Piantadosi S; Burger PC; Brem H Cancer Chemother Pharmacol; 1997; 39(5):383-9. PubMed ID: 9054951 [TBL] [Abstract][Full Text] [Related]
5. Interstitial chemotherapy of experimental brain tumors: comparison of intratumoral injection versus polymeric controlled release. Buahin KG; Brem H J Neurooncol; 1995 Nov; 26(2):103-10. PubMed ID: 8787852 [TBL] [Abstract][Full Text] [Related]
6. Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma. Frazier JL; Wang PP; Case D; Tyler BM; Pradilla G; Weingart JD; Brem H J Neurooncol; 2003 Sep; 64(3):203-9. PubMed ID: 14558595 [TBL] [Abstract][Full Text] [Related]
7. Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors. Sampath P; Hanes J; DiMeco F; Tyler BM; Brat D; Pardoll DM; Brem H Cancer Res; 1999 May; 59(9):2107-14. PubMed ID: 10232596 [TBL] [Abstract][Full Text] [Related]
8. The role of minocycline in the treatment of intracranial 9L glioma. Weingart JD; Sipos EP; Brem H J Neurosurg; 1995 Apr; 82(4):635-40. PubMed ID: 7897527 [TBL] [Abstract][Full Text] [Related]
9. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model. Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548 [TBL] [Abstract][Full Text] [Related]
10. Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain. Tamargo RJ; Myseros JS; Epstein JI; Yang MB; Chasin M; Brem H Cancer Res; 1993 Jan; 53(2):329-33. PubMed ID: 8417826 [TBL] [Abstract][Full Text] [Related]
11. Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma. Storm PB; Renard VM; Moriarity JL; Tyler B; Wilentz RE; Brem H; Weingart JD Cancer Chemother Pharmacol; 2004 Oct; 54(4):361-7. PubMed ID: 15197484 [TBL] [Abstract][Full Text] [Related]
12. Injection of chemotherapeutic microspheres and glioma. IV: Eradicating tumors in rats. Emerich DF; Winn SR; Bartus RT Cell Transplant; 2002; 11(1):47-54. PubMed ID: 12095219 [TBL] [Abstract][Full Text] [Related]
13. Interstitial docetaxel (taxotere), carmustine and combined interstitial therapy: a novel treatment for experimental malignant glioma. Sampath P; Rhines LD; DiMeco F; Tyler BM; Park MC; Brem H J Neurooncol; 2006 Oct; 80(1):9-17. PubMed ID: 16636748 [TBL] [Abstract][Full Text] [Related]
14. Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors. Hanes J; Sills A; Zhao Z; Suh KW; Tyler B; DiMeco F; Brat DJ; Choti MA; Leong KW; Pardoll DM; Brem H Pharm Res; 2001 Jul; 18(7):899-906. PubMed ID: 11496947 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas. Judy KD; Olivi A; Buahin KG; Domb A; Epstein JI; Colvin OM; Brem H J Neurosurg; 1995 Mar; 82(3):481-6. PubMed ID: 7861228 [TBL] [Abstract][Full Text] [Related]
16. Local delivery of chemotherapy prolongs survival in experimental brain metastases from breast carcinoma. Ewend MG; Sampath P; Williams JA; Tyler BM; Brem H Neurosurgery; 1998 Nov; 43(5):1185-93. PubMed ID: 9802862 [TBL] [Abstract][Full Text] [Related]
17. Intralesionally implanted cisplatin plus systemic carmustine for the treatment of brain tumor in rats. Kong Q; Kleinschmidt-DeMasters BK; Lillehei KO J Surg Oncol; 1998 Oct; 69(2):76-82. PubMed ID: 9808509 [TBL] [Abstract][Full Text] [Related]
19. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain. Brem H; Tamargo RJ; Olivi A; Pinn M; Weingart JD; Wharam M; Epstein JI J Neurosurg; 1994 Feb; 80(2):283-90. PubMed ID: 8283268 [TBL] [Abstract][Full Text] [Related]
20. Increased tumor cures using combined radiosurgery and BCNU in the treatment of 9l glioma in the rat brain. Khil MS; Kolozsvary A; Apple M; Kim JH Int J Radiat Oncol Biol Phys; 2000 May; 47(2):511-6. PubMed ID: 10802380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]